Jenkins Annalisa
- SEC CIK
- 0001639481
No open-market purchases or sales filed in the past year.
Current role at each company
- SKYE Skye Bioscience, Inc.Directoras of Apr 2, 2026
- MREO Mereo BioPharma Group plcDirectoras of Feb 27, 2026
- CMPS COMPASS Pathways plcDirectoras of Jun 13, 2025
- TECX Tectonic Therapeutic, Inc.Directoras of Jun 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jenkins Annalisa as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CMPS COMPASS Pathways plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Jenkins AnnalisaDirector | SSale | −3.38K | $12.48 | −$42.2K | −14.3%20.4K after |